How do you approach adjuvant therapy in patients who have a poor clinical response to neoadjuvant endocrine therapy?
No prior chemotherapy.
Answer from: Medical Oncologist at Academic Institution
While there is little clinical trial experience to support this, I think that it is useful to differentiate between patients with indolent cancers that are unlikely to respond, clinically or pathologically, to either neoadjuvant endocrine therapy - even after 6 months of treatment - o...
This is the reason I rarely use neoadjuvant endocr...